<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Res</journal-id><journal-id journal-id-type="pmc-domain-id">892</journal-id><journal-id journal-id-type="pmc-domain">vetres</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6882340</article-id><article-id pub-id-type="pmcid-ver">PMC6882340.1</article-id><article-id pub-id-type="pmcaid">6882340</article-id><article-id pub-id-type="pmcaiid">6882340</article-id><article-id pub-id-type="pmid">31775863</article-id><article-id pub-id-type="doi">10.1186/s13567-019-0717-0</article-id><article-id pub-id-type="publisher-id">717</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Brucella melitensis</italic> Rev.1 vaccination generates a higher shedding risk of the vaccine strain in Alpine ibex (<italic toggle="yes">Capra ibex</italic>) compared to the domestic goat (<italic toggle="yes">Capra hircus</italic>)</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Ponsart</surname><given-names initials="C">Claire</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Riou</surname><given-names initials="M">Micka&#235;l</given-names></name><address><email>mickael.riou@inra.fr</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Locatelli</surname><given-names initials="Y">Yann</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Jacques</surname><given-names initials="I">Isabelle</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fadeau</surname><given-names initials="A">Alain</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jay</surname><given-names initials="M">Maryne</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Simon</surname><given-names initials="R">Roland</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Perrot</surname><given-names initials="L">Ludivine</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Freddi</surname><given-names initials="L">Luca</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Breton</surname><given-names initials="S">Sylvain</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chaumeil</surname><given-names initials="T">Thierry</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Blanc</surname><given-names initials="B">Barbara</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ortiz</surname><given-names initials="K">Katia</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vion</surname><given-names initials="C">Colin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rioult</surname><given-names initials="D">Damien</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Qu&#233;m&#233;r&#233;</surname><given-names initials="E">Erwan</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sarradin</surname><given-names initials="P">Pierre</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chollet</surname><given-names initials="JY">Jean-Yves</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garin-Bastuji</surname><given-names initials="B">Bruno</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Rossi</surname><given-names initials="S">Sophie</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0584 7022</institution-id><institution-id institution-id-type="GRID">grid.15540.35</institution-id><institution>EU/OIE/FAO &amp; National Reference Laboratory for Animal Brucellosis, Animal Health Laboratory, </institution><institution>ANSES/Paris-Est University, </institution></institution-wrap>94706 Maisons-Alfort, France </aff><aff id="Aff2"><label>2</label>UE-1277 Plateforme d&#8217;Infectiologie exp&#233;rimentale (PFIE), INRA Centre Val de Loire, 37380 Nouzilly, France </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2174 9334</institution-id><institution-id institution-id-type="GRID">grid.410350.3</institution-id><institution>R&#233;serve Zoologique de la Haute Touche, Mus&#233;um National d&#8217;Histoire Naturelle (MNHN), </institution></institution-wrap>36290 Obterre, France </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2182 6141</institution-id><institution-id institution-id-type="GRID">grid.12366.30</institution-id><institution>D&#233;partement G&#233;nie Biologique, </institution><institution>Institut Universitaire Technologique (IUT), Universit&#233; de Tours, </institution></institution-wrap>29 Rue du Pont Volant, 37082 Tours Cedex 2, France </aff><aff id="Aff5"><label>5</label>UMR-1282 Infectiologie et Sant&#233; Publique (ISP), INRA Centre Val de Loire &#8211; Universit&#233; de Tours, 37380 Nouzilly, France </aff><aff id="Aff6"><label>6</label>Laboratoire de Touraine, Conseil d&#233;partemental d&#8217;Indre-et-Loire, B.P. 67357, 37073 Tours Cedex 02, France </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0618</institution-id><institution-id institution-id-type="GRID">grid.11667.37</institution-id><institution>Universit&#233; de Reims Champagne-Ardenne, </institution></institution-wrap>9 Boulevard de la Paix, 51100 Reims, France </aff><aff id="Aff8"><label>8</label>Unit&#233; Comportement et &#201;cologie de la Faune Sauvage (CEFS), INRA, 24 chemin de Borde-Rouge-Auzeville CS 52627, 31326 Castanet-Tolosan Cedex, France </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0638 7840</institution-id><institution-id institution-id-type="GRID">grid.436956.b</institution-id><institution>Unit&#233; sanitaire de la Faune, Direction de la Recherche et de l&#8217;Expertise (DRE), </institution><institution>Office National de la Chasse et de la Faune Sauvage (ONCFS), </institution></institution-wrap>5 rue de Saint-Thibaud, Saint-Beno&#238;t, 78610 Auffargis, France </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0584 7022</institution-id><institution-id institution-id-type="GRID">grid.15540.35</institution-id><institution>European and International Affairs Department, </institution><institution>ANSES, </institution></institution-wrap>94701 Maisons-Alfort, France </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="ppub"><year>2019</year></pub-date><volume>50</volume><issue-id pub-id-type="pmc-issue-id">327125</issue-id><elocation-id>100</elocation-id><history><date date-type="received"><day>6</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>11</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>03</day><month>12</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-10-19 18:25:21.383"><day>19</day><month>10</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="13567_2019_Article_717.pdf"/><abstract id="Abs1"><p id="Par1">Epidemiological investigations implemented in wild and domestic ruminants evidenced a reservoir for <italic toggle="yes">Brucella</italic> in <italic toggle="yes">Capra ibex</italic> in the French Alps. Vaccination was considered as a possible way to control <italic toggle="yes">Brucella</italic> infection in this wildlife population. Twelve ibexes and twelve goats were allocated into four groups housed separately, each including six males or six non-pregnant females. Four to five animals were vaccinated and one or two animals were contact animals. Half of the animals were necropsied 45&#160;days post-vaccination (pv), and the remaining ones at 90&#160;days pv. Additional samples were collected 20 and 68&#160;days pv to explore bacterial distribution in organs and humoral immunity. Neither clinical signs nor <italic toggle="yes">Brucella</italic>-specific lesions were observed and all vaccinated animals seroconverted. <italic toggle="yes">Brucella</italic> distribution and antibody profiles were highly contrasted between both species. Proportion of infected samples was significantly higher in ibex compared to goats and decreased between 45 and 90&#160;days pv. Two male ibex presented urogenital excretion at 20 or 45&#160;days pv. The bacterial load was higher 45&#160;days in ibexes compared to goats, whereas it remained moderate to low 90&#160;days pv in both species with large variability between animals. In this experiment, differences between species remained the main source of variation, with low impact of other individual factors. To conclude, multiplicative and shedding capacity of Rev.1 was much higher in ibex compared to goats within 90&#160;days. These results provide initial information on the potential use <italic toggle="yes">in natura</italic> of a commercial vaccine.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100011004</institution-id><institution>Minist&#232;re de l'Agriculture et de l'Alimentation</institution></institution-wrap></funding-source><award-id>020602002001</award-id><award-id>2017-104</award-id><principal-award-recipient><name name-style="western"><surname>Riou</surname><given-names>Micka&#235;l</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Minist&#232;re de l'Ecologie et de la transition solidaire</institution></funding-source><award-id>2102054258</award-id><principal-award-recipient><name name-style="western"><surname>Locatelli</surname><given-names>Yann</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par12"><italic toggle="yes">Brucella melitensis</italic> is a Gram-negative facultative intracellular bacterium responsible for brucellosis in small ruminants, a widespread zoonosis in many sheep- and goat-raising countries worldwide [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par13">Brucellosis eradication in small ruminants has been achieved in most of European Union (EU) countries through the implementation of long-term management programs combining vaccination with serological testing and culling [<xref ref-type="bibr" rid="CR5">5</xref>]. Until recently, terrestrial wildlife had not been considered as a significant reservoir [<xref ref-type="bibr" rid="CR6">6</xref>]. In France, no brucellosis cases have been reported in domestic ruminants since 2003 [<xref ref-type="bibr" rid="CR7">7</xref>]. However, <italic toggle="yes">B. melitensis</italic> biovar 3 infection has been identified since 2012 in Alpine ibexes (<italic toggle="yes">Capra ibex</italic>) in the Bargy Mountains (Haute Savoie, France), after a local outbreak on a dairy cattle farm and two human cases declared in 2011 [<xref ref-type="bibr" rid="CR8">8</xref>&#8211;<xref ref-type="bibr" rid="CR10">10</xref>]. The restriction of brucellosis to the Bargy area indicates a localized outbreak in wildlife. Until recently, Alpine ibexes had been considered to be epidemiological dead-ends for <italic toggle="yes">B. melitensis</italic> [<xref ref-type="bibr" rid="CR6">6</xref>], but the high prevalence observed in the Bargy area (38%) suggested the presence of an unexpected wildlife reservoir [<xref ref-type="bibr" rid="CR11">11</xref>]. Focused culling of seropositive or ill ibexes and mass culling have been implemented since 2013, which reduced the population by half [<xref ref-type="bibr" rid="CR12">12</xref>], raising the question of the social acceptability of conducting mass culling in a protected species [<xref ref-type="bibr" rid="CR11">11</xref>]. Moreover, this management strategy did not result in a significant reduction in seroprevalence [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par14">A scientific expert appraisal suggested that vaccination with the <italic toggle="yes">B. melitensis</italic> Rev.1 strain of ibex could be considered for better control of this wildlife reservoir [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. The Rev.1 vaccine, a stable live <italic toggle="yes">B. melitensis</italic> attenuated strain [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], administered by the conjunctival route at standard doses is well known to induce good protection in sheep and goats against <italic toggle="yes">B. melitensis</italic>-related abortion [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The main risks of vaccination are potential abortion in female animals vaccinated during pregnancy and possible Rev.1 genital or milk excretion following vaccination [<xref ref-type="bibr" rid="CR19">19</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref>]. Despite the phylogenetic closeness of ibex and domestic goats (<italic toggle="yes">Capra hircus</italic>) [<xref ref-type="bibr" rid="CR24">24</xref>], experts have highlighted the importance of confirming vaccine safety in Alpine ibex before its application <italic toggle="yes">in natura</italic> [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], taking into account the other potential negative impacts of a live <italic toggle="yes">Brucella</italic> vaccine reported in other wildlife species [<xref ref-type="bibr" rid="CR26">26</xref>&#8211;<xref ref-type="bibr" rid="CR30">30</xref>], and potential interference with local monitoring and management programs [<xref ref-type="bibr" rid="CR25">25</xref>]. It was therefore decided to design a study aimed at checking the innocuousness of Rev.1 in non-pregnant sexually mature ibexes that are the most common captured/sampled age class (juveniles being, on the contrary, rarely captured) [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par15">Because of ethical, regulatory, logistic and practical reasons, a virulent challenge in pregnant Alpine ibex requiring a biosafety level 3 (BSL-3) facility adapted to this wildlife species could not be considered [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par16">Therefore, the objective of the present study was to assess the innocuousness of the Rev.1 conjunctival vaccine in non-pregnant sexually mature Alpine ibexes compared to domestic goats, and the subsequent risk of shedding and transmission to unvaccinated control animals. The hypothesis tested here was that sexually mature ibexes and goats have a comparable ability to control the vaccine.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par17">All experiments were conducted in accordance with EU guidelines and French regulations (Directive 2010/63/EU, 2010; French Rural Code, 2018; French Decree No. 2013-118, 2013, [<xref ref-type="bibr" rid="CR31">31</xref>]). All experimental procedures were evaluated and approved by the Ministry of Higher Education and Research (Notifications: APAFIS#7643-2016112111336721 v4 and APAFlS#7913-2016112911444302 v3). Procedures concerning goats were evaluated by the Ethics Committee of the Val de Loire (CEEA VdL, committee No. 19, APAFIS#7643) and took place at the INRA Experimental Infection Platform [<xref ref-type="bibr" rid="CR32">32</xref>], whereas procedures for ibex were evaluated by the Cuvier Ethics Committee (CEEA Cuvier, Committee No. 68, APAFIS#7913) and took place at the <italic toggle="yes">R&#233;serve Zoologique de la Haute Touche</italic> (RZHT, Obterre, France).</p><sec id="Sec3"><title>Selection of animals</title><p id="Par18">A major difficulty in the present study was to pair goats and ibexes regarding their sexual maturity and health status, which is known to impact individual susceptibility to <italic toggle="yes">Brucella</italic> rather than age, since sexual maturity in ibex is much later (2 to 5&#160;years) compared to the domestic goat. Goats, on the contrary, are seldom raised for more than 4&#8211;5&#160;years (roughly 4&#8211;6&#160;months for bucks and 6&#8211;18&#160;months for goats [<xref ref-type="bibr" rid="CR33">33</xref>]). Six male and six non-pregnant female ibexes were recruited from three zoological parks (Parc des Angles, Domaine de Pescheray and RZHT, France). For the experiment, males and females were housed separately at the RZHT in two groups in a 170&#160;m<sup>2</sup> facility specifically adapted to their welfare. Animal age ranged between 2.5 and 5&#160;years (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p><bold>Individual characteristics of the 12</bold>
<bold><italic toggle="yes">Capra ibex</italic></bold>
<bold>and 12</bold>
<bold><italic toggle="yes">Capra hircus</italic></bold>
<bold>included in the study and applied vaccine treatment</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Species</th><th align="left" colspan="1" rowspan="1">Group</th><th align="left" colspan="1" rowspan="1">Housing</th><th align="left" colspan="1" rowspan="1">Birth date</th><th align="left" colspan="1" rowspan="1">Identifier</th><th align="left" colspan="1" rowspan="1">Sex</th><th align="left" colspan="1" rowspan="1">Age (years)</th><th align="left" colspan="1" rowspan="1">Treatment</th><th align="left" colspan="1" rowspan="1">Day of necropsy</th></tr></thead><tbody><tr><td align="left" rowspan="6" colspan="1"><italic toggle="yes">Capra ibex</italic></td><td align="left" rowspan="6" colspan="1">A</td><td align="left" rowspan="6" colspan="1">Haute Touche</td><td align="left" colspan="1" rowspan="1">01/05/2013</td><td char="." align="char" colspan="1" rowspan="1">1890</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2013</td><td char="." align="char" colspan="1" rowspan="1">2000</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2012</td><td char="." align="char" colspan="1" rowspan="1">1895</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Control</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2012</td><td char="." align="char" colspan="1" rowspan="1">1839</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2014</td><td char="." align="char" colspan="1" rowspan="1">1828</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2014</td><td char="." align="char" colspan="1" rowspan="1">3094</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" rowspan="6" colspan="1"><italic toggle="yes">Capra ibex</italic></td><td align="left" rowspan="6" colspan="1">B</td><td align="left" rowspan="6" colspan="1">Haute Touche</td><td align="left" colspan="1" rowspan="1">01/05/2012</td><td char="." align="char" colspan="1" rowspan="1">1926</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Control</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2012</td><td char="." align="char" colspan="1" rowspan="1">1920</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2012</td><td char="." align="char" colspan="1" rowspan="1">1933</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2013</td><td char="." align="char" colspan="1" rowspan="1">2393</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">01/05/2014</td><td char="." align="char" colspan="1" rowspan="1">2349</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Control</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">31/05/2002</td><td char="." align="char" colspan="1" rowspan="1">7462</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&gt;&#8201;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" rowspan="6" colspan="1"><italic toggle="yes">Capra hircus</italic></td><td align="left" rowspan="6" colspan="1">C</td><td align="left" rowspan="6" colspan="1">PFIE</td><td align="left" colspan="1" rowspan="1">31/08/2015</td><td char="." align="char" colspan="1" rowspan="1">62&#160;107</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">04/02/2016</td><td char="." align="char" colspan="1" rowspan="1">16&#160;142</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">16/02/2016</td><td char="." align="char" colspan="1" rowspan="1">06&#160;145</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">14/02/2016</td><td char="." align="char" colspan="1" rowspan="1">61&#160;003</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D45</td></tr><tr><td align="left" colspan="1" rowspan="1">15/02/2016</td><td char="." align="char" colspan="1" rowspan="1">61&#160;275</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">03/12/2012</td><td char="." align="char" colspan="1" rowspan="1">13&#160;101</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Control</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" rowspan="6" colspan="1"><italic toggle="yes">Capra hircus</italic></td><td align="left" rowspan="6" colspan="1">D</td><td align="left" rowspan="6" colspan="1">PFIE</td><td align="left" colspan="1" rowspan="1">30/08/2010</td><td char="." align="char" colspan="1" rowspan="1">10&#160;139*</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&gt;&#8201;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">19/02/2017<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">26/08/2011</td><td char="." align="char" colspan="1" rowspan="1">20&#160;055*</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&gt;&#8201;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">27/03/2017<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">07/09/2012</td><td char="." align="char" colspan="1" rowspan="1">30&#160;313*</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">12/02/2017<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">31/08/2013</td><td char="." align="char" colspan="1" rowspan="1">40&#160;176</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">3&#8211;5</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">02/09/2014</td><td char="." align="char" colspan="1" rowspan="1">50&#160;105</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;3</td><td align="left" colspan="1" rowspan="1">Vaccinated</td><td align="left" colspan="1" rowspan="1">D90</td></tr><tr><td align="left" colspan="1" rowspan="1">27/08/2011</td><td char="." align="char" colspan="1" rowspan="1">20&#160;072</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">&gt;&#8201;5</td><td align="left" colspan="1" rowspan="1">Control</td><td align="left" colspan="1" rowspan="1">D90</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Death of 3 goats occurred during the experiment, only goat 20&#160;055 was included in the analysis.</p><p>*Corresponding to the number of death of 3 goats.</p></table-wrap-foot></table-wrap>
</p><p id="Par19">Twelve adult Alpine goats (six non-pregnant females and six males) were obtained from the INRA animal facility in Magneraud (France) and the company CAPGENES (CAPGENES, Agropole, Mignaloux-Beauvoir, France) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). During the trial, all animals were housed in the animal facilities, biosafety level 1 sheepfold animal facility at the INRA PFIE (INRA Centre de Recherche Val de Loire, Nouzilly, France).</p></sec><sec id="Sec4"><title>Vaccination and sampling</title><p id="Par20">The experiment (Figure&#160;<xref rid="Fig1" ref-type="fig">1</xref>) consisted in the conjunctival vaccination with Rev.1 vaccine (Ocurev<sup>&#174;</sup>, CZ Veterinaria, Spain; 1&#8211;2&#8201;&#215;&#8201;10<sup>9</sup> CFU in 35&#160;&#181;L/doses) of 10 goats (divided into two groups: five females and five males) and 9 ibex (divided in two groups: four females and five males; the 5th female ibex was not vaccinated and kept as a contact animal, as diarrhea symptoms were observed on the day of vaccination). At the time of the vaccination, vaccinated animals and contacts were separated from each other in captivity to avoid iatrogenic interference. The animals included in the experiment were neither pregnant nor lactating. For both species, one animal of each sex was used as an unvaccinated contact control, except for the female ibex (two contact controls). Vaccination was systematically performed according to the recommendations of the manufacturer for sheep and goats in the right eyelid. Within each batch, half of the animals (2 individuals vaccinated and 1 control) were euthanized at 45&#160;days pv and the remaining animals at 90&#160;days after anesthesia induction by ketamine/xylazine mixture (Imalgene<sup>&#174;</sup> 1000, Merial, France, 10&#160;mg/kg and Rompun<sup>&#174;</sup>, Bayer Healthcare, France, 2&#160;mg/kg administered IM). Euthanasia took place on anesthetized animals by IV injection of Euthasol<sup>&#174;</sup> (Euthasol<sup>&#174;</sup>Vet 40%, LE VET, Netherlands, 1&#160;mL/5&#160;kg) for ibex and Dolethal<sup>&#174;</sup> (Vetoquinol, France, 250&#160;mL, 50&#160;mg/kg) for goats. All animals were then necropsied.<fig id="Fig1" position="float" orientation="portrait"><label>Figure&#160;1</label><caption><p><bold>Experimental design of vaccination with</bold>
<bold><italic toggle="yes">Brucella melitensis</italic></bold>
<bold>Rev.1 strain of</bold>
<bold><italic toggle="yes">Capra ibex</italic></bold>
<bold>and</bold>
<bold><italic toggle="yes">C. hircus.</italic></bold>
<bold>A</bold> Experimental design of ocular vaccination in <italic toggle="yes">Capra ibex</italic> and <italic toggle="yes">hircus</italic> and <bold>B</bold> inoculation of OCUREV<sup>&#174;</sup> vaccine by ocular pathway at 1&#8201;&#215;&#8201;10<sup>9</sup>&#160;CFU/drop.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="13567_2019_717_Fig1_HTML.jpg"/></fig>
</p><p id="Par21">Serological, bacterial, hematological and hormonal follow-ups were performed at 0, 20, 45, 68, and 90&#160;days pv with an additional blood sample at 7&#160;days pv for goats. In parallel, ocular, nasal and vaginal or urethral swabs were collected for culture purposes (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Blood samples were collected by jugular venipuncture from all animals. They were prepared for bacteriological culture and assessment of serological response. All animals were blood-tested to check the seroconversion of vaccinated animals and potential exposure to the vaccine strain of unvaccinated contact animals. Vaginal and urethral swabs were performed in females and males, respectively. Ocular and nasal swabs were collected from the inoculated head-side in vaccinated animals and from both sides in contact animals (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Swabs were prepared for bacteriological culture.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p><bold>Swab and blood collection on days 0, 20, 45, 68 and 90, and urine and tissue collection at necropsy on day 45 or 90 after conjunctival vaccination on day 0 with the</bold>
<bold><italic toggle="yes">B. melitensis</italic></bold>
<bold>Rev.1 strain</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Vaccinated animals</th><th align="left" colspan="1" rowspan="1">Contact animals</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Collection during post-vaccination kinetics</td><td align="left" colspan="1" rowspan="1">Ocular and nasal swabs</td><td align="left" colspan="1" rowspan="1">Ocular and nasal swabs</td></tr><tr><td align="left" colspan="1" rowspan="1">From the inoculated head-side (1 swab)</td><td align="left" colspan="1" rowspan="1">From both head-sides (2 swabs)</td></tr><tr><td align="left" colspan="1" rowspan="1">Vaginal and urethral swabs/blood</td><td align="left" colspan="1" rowspan="1">Vaginal and urethral swabs/blood</td></tr><tr><td align="left" rowspan="5" colspan="1">Collection at necropsy</td><td align="left" colspan="1" rowspan="1">Head lymph nodes</td><td align="left" colspan="1" rowspan="1">Head lymph nodes</td></tr><tr><td align="left" colspan="1" rowspan="1">From the inoculated head-side</td><td align="left" colspan="1" rowspan="1">From both head-sides and pooled</td></tr><tr><td align="left" colspan="1" rowspan="1">Iliac, supramammary and inguinal lymph nodes from both sides and pooled</td><td align="left" colspan="1" rowspan="1">Iliac, supramammary and inguinal
lymph nodes from both sides and pooled</td></tr><tr><td align="left" colspan="1" rowspan="1">Spleen</td><td align="left" colspan="1" rowspan="1">Spleen</td></tr><tr><td align="left" colspan="1" rowspan="1">Urine aspirated from bladder</td><td align="left" colspan="1" rowspan="1">Urine aspirated from bladder</td></tr></tbody></table></table-wrap>
</p><p id="Par22">As environmental samples, five manure samples per pen were also collected on day 68 pv in both locations (female and male pens).</p></sec><sec id="Sec5"><title>Necropsy, tissue collection and preparation</title><p id="Par23">Necropsies, in a BSL-3 necropsy room, were performed at the PFIE. Urine was collected during necropsy (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Tissues removed aseptically included parotid, retropharyngeal, sub-maxillary (head lymph nodes), uterus (female) or testes (male), supra-mammary (female) or inguinal (male) and iliac lymph nodes (pelvic organs), pre-scapular lymph nodes, and spleen (Figures&#160;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>). Tissue samples were prepared according to OIE requirements [<xref ref-type="bibr" rid="CR17">17</xref>] (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Other specimens were kept frozen at &#8722;80&#160;&#176;C.<fig id="Fig2" position="float" orientation="portrait"><label>Figure&#160;2</label><caption><p><bold>Organ/swab classification according to localization and shedding potential in both goats and Alpine ibexes.</bold> (1) lymph nodes from the head (local multiplication), (2) nasal and ocular swabs (low shedding potential), (3) blood, (4) lymph nodes from the pelvic area (urogenital multiplication and potential shedding), (5) genital or bladder swabs (high shedding potential).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="13567_2019_717_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec6"><title>Control of the Rev.1 vaccine batch</title><p id="Par24">Concentrations of bacteria in the Ocurev<sup>&#174;</sup> vaccine batch (number 164164) was previously controlled by the French National Reference Laboratory (NRL) for brucellosis by standard plate counts in accordance with OIE requirements [<xref ref-type="bibr" rid="CR17">17</xref>] and approved before use. Moreover, one Ocurev<sup>&#174;</sup> vaccine vial used for goat vaccination was controlled for purity and colonial morphology after conjunctival instillation, according to the same procedure.</p></sec><sec id="Sec7"><title>Zootechnical monitoring and behavior</title><p id="Par25">Animal welfare was monitored twice per day by assessing and scoring the following four general categories: (a) behavior, (b) thermal comfort, (c) feeding, and (d) body condition. An endpoint to the experimental procedure was planned according to scoring in case major clinical signs of pain and distress would have been observed: hyperthermia (&gt;&#8201;41&#160;&#176;C), prostration, anorexia, diarrhea and/or vomiting, significant weight loss, tissue necrosis, biting.</p></sec><sec id="Sec8"><title>Blood cell analyses</title><p id="Par26">Blood cells were counted with a MS9-5 Hematology Counter<sup>&#174;</sup> (digital automatic hematology analyzer, Melet Schloesing Laboratories, France) and analyzed to characterize total white blood cells, red blood cells, and platelets [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec9"><title>Bacteriological cultures</title><sec id="Sec10"><title>Specimen preparation</title><p id="Par27">Tissue samples and swabs were transferred to the bacteriology laboratory within 2&#160;h following necropsies and then directly handled as following: tissue samples were mixed in a tissue grinder with sterile PBS (two-fold dilution), before being inoculated onto solid media. Each swab was rehydrated in PBS, before being streaked directly onto two plates, then incubated at 37&#160;&#176;C. Whole blood was centrifuged (600 <italic toggle="yes">g</italic>, 15&#160;min). The concentrate was diluted 1:6 in a trypticase soy broth with 5% vol./vol. equine serum. Broths were incubated in a 5% CO<sub>2</sub> added-atmosphere at 37&#160;&#176;C. Subcultures were initiated every 3&#160;days using Farrell&#8217;s solid medium (0.2&#160;mL of broth/dish) until 35&#160;days.</p><p id="Par28">Manure samples were cut and diluted 1:2 in sterile PBS, then incubated overnight at 37&#160;&#176;C, before DNA extraction for molecular detection [<xref ref-type="bibr" rid="CR38">38</xref>] and culture for bacterial detection. For this particular matrix, the lower limit of detection was determined from manure samples spiked with calibrated broth suspensions of <italic toggle="yes">B. melitensis</italic> biovar 3 (Ether-ATCC 23458).</p></sec><sec id="Sec11"><title>Culture protocol</title><p id="Par29">Culture of blood, swabs and tissue samples was performed on selective modified Farrell&#8217;s medium formulated from non-selective solid agar medium and <italic toggle="yes">Brucella</italic> selective supplement (Blood Agar Base No. 2, OXOID CM0271, supplemented with modified <italic toggle="yes">Brucella</italic> Selective Supplement, OXOID SR0209 and 5% vol./vol. equine serum). Each specimen (0.2&#160;mL of prepared specimen) was incubated on 4 plates at 37&#160;&#176;C. The plates were checked for up to 10&#160;days for the presence of bacterial growth; strains were then isolated and identified using a combination of growth characteristics and bacteriological methods [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Molecular identification included real-time PCR and Bruce-ladder methods [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>].</p></sec></sec><sec id="Sec12"><title>Serological analyses</title><p id="Par30">Blood samples were processed according to standard procedures in a BSL-3 laboratory. Whole blood was centrifuged (600 <italic toggle="yes">g</italic>, 15&#160;min). Sera were examined for the presence of smooth <italic toggle="yes">Brucella</italic> antibodies using RBT (Pourquier<sup>&#174;</sup> Rose Bengal Ag, IDEXX) and CFT (Pourquier<sup>&#174;</sup> CFT Brucellosis Ag, IDEXX) antigens. The lowest detection limits for CFT assays were determined and expressed as CFT titers (ICFTU/mL). Both antigens were standardized against the OIE International Standard Serum (OIEISS, APHA, Weybridge, UK) and the test performed according to OIE and EU requirements (any visible agglutination reaction was considered positive for RBT; positivity threshold of 20&#160;ICFTU/mL for CFT). RBT results were expressed as a score ranging from 0 (no visible agglutination) to 4 (complete agglutination).</p></sec><sec id="Sec13"><title>Statistical analyses</title><p id="Par31">Serological results from vaccinated animals were analyzed according to three criteria: (i) the score of agglutination with the RBT, from 0 (no agglutination) to 4 (complete agglutination); (ii) the CFT titer (ICFTU/mL) corresponding to the end-point of the reaction; and (iii) the individual serological status combining RBT and CFT results: seropositive (positive results with RBT and CFT) or seronegative (negative results with RBT or CFT). To account for the cluster effect of each individual, a mixed model was used, the identity of each individual being used as a random effect [<xref ref-type="bibr" rid="CR41">41</xref>]. The fixed effects accounted for in serology were the species (ibex, goat), the time of sampling (20, 45, 68, 90&#160;days pv), and the presence of bacteremia on day 20 pv (yes/no). Sex of animals was tested as fixed effect but was not kept in the final model as it didn&#8217;t improve significantly the model fitness.</p><p id="Par32">We analyzed bacteriological results from vaccinated animals according to different &#8220;innocuousness criteria&#8221; accounting for Rev.1 dissemination and the individual ability to contain the live-vaccine: (i) an indicator of Rev.1 strain dissemination among vaccinated individuals, by considering the proportion of organs positive to culture, (ii) an indicator of vaccine strain shedding potential among vaccinated individuals, by considering the proportion of culture-positive organs from the pelvic area; and (iii) the bacterial burden among infected organs or swabs. We analyzed hematological results from vaccinated or non-vaccinated animals according to different &#8220;innocuousness criteria&#8221; after Rev.1 vaccination in function of time, sex and genders, using GraphPad Prism software version 5.0 (non-parametric tests: Kruskall-Wallis, Mann&#8211;Whitney tests, GraphPad<sup>&#174;</sup>, San Diego, Ca, USA).</p><p id="Par33">The two first variables were defined as the proportion of culture-positive organs/swabs/blood sampled on each vaccinated individual and at each sampling time, either at the whole animal level (i) or only the pelvic organs. (ii) Animals excluded from the study before the 20th day post-vaccination (i.e., two dead female goats) were not included in these analyses. To account for the cluster effect of each individual, a logistic mixed model was used, the identity of each individual being used as a random effect [<xref ref-type="bibr" rid="CR42">42</xref>]. The fixed effects accounted for were species, gender, time of sampling (20, 45, 68, 90&#160;days pv), and type of sampling event (in vivo sampling, necropsy). The third variable was defined as the total number of colonies counted among the culture-positive organs or swabs. (iii) This variable was log-transformed and modelled according to a Gaussian mixed model (random effect). This analysis focused on necropsy samples only (i.e. days 45 or 90 pv). The number of plates was variable among organs (from 1 to 4), mainly due to varying organ/swab nature or size; the number of plates was thus introduced as a model offset. The fixed effects accounted for were species, gender, time of necropsy, and type of organ (Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par34">Model selection was based on the Akaike Information Criterion (AIC, [<xref ref-type="bibr" rid="CR43">43</xref>]). Statistical analyses were performed using R software version 3.4.2 (the R foundation for statistical computing, 2017), and the lme4 [<xref ref-type="bibr" rid="CR44">44</xref>] and MuMIn packages [<xref ref-type="bibr" rid="CR45">45</xref>].</p></sec></sec><sec id="Sec14"><title>Results</title><sec id="Sec15"><title>Vaccine control testing</title><p id="Par35">The control of the Rev.1 vaccine strain performed post-vaccination showed that the strain was pure and smooth. Actual concentration measured by viable counts on TSA-YE medium, 1.6&#8201;&#215;&#8201;10<sup>9</sup> CFU/dose, was consistent with that of the manufacturer (1 to 2&#8201;&#215;&#8201;10<sup>9</sup> CFU/dose).</p></sec><sec id="Sec16"><title>Zootechnical monitoring and behavior</title><sec id="Sec17"><title>Ibexes</title><p id="Par36">No clinical signs were observed during the acclimatization phase. The experimental protocol therefore focused on nine vaccinated animals (five males and four females) and three contact controls (one male and two females). During the experiment, clinical follow-up of the animals showed episodic diarrhea (a gastro-intestinal food supplement of the Phoscargil<sup>&#174;</sup> type (San&#8217;Elevage, Chang&#233;, France) was administered to all the animals); one diarrheic female ibex was not vaccinated for this reason and included as a control. No major hyperthermia, polypnea, tachycardia, prostration, anorexia, weight loss or complaints were observed in the animals. Furthermore, in both live animals and at autopsy, no gross lesions suggestive of brucellosis infection (such as described by Freycon et al. and Lambert et al. [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]) were observed in vaccinated or contact animals, particularly in the genitalia, udder or joints. No loss of appetite or body condition, trauma, or aggressive behavior were observed, despite close contact between individuals of the same batch over an extended period of 3&#160;months.</p></sec><sec id="Sec18"><title>Goats</title><p id="Par37">No clinical signs were observed during the acclimatization phase nor during vaccination of the goats, except for a buck that had strong nasal discharge on day 5&#160;pv, which then resolved without treatment. Nevertheless, two vaccinated female goats died without clinical signs on day 6 and day 13&#160;pv, respectively probably in connection with other concomitant diseases and poor body condition of the latter. A third vaccinated goat showed post-vaccination mastitis on day 42 and was euthanized on day 43 for animal welfare reasons (exceeded endpoints).</p></sec></sec><sec id="Sec19"><title>Total and differential white blood cell counts in the blood</title><p id="Par38">In addition to significant individual variability, blood counts varied with treatment (vaccination/contact), post-vaccination stage, species, and sex of animals. There was no sex effect on hematological parameters, but a significant effect of species was observed especially for total number of white cells (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05). Following vaccination, a significant decrease in the concentration of white blood cells was observed in both vaccine species on D45 and D90 (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05; Figures&#160;<xref rid="Fig3" ref-type="fig">3</xref>A and B). No significant decrease during follow-up kinetics was observed in unvaccinated animals. However, the difference between species remained significant throughout the experimental period (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05).<fig id="Fig3" position="float" orientation="portrait"><label>Figure&#160;3</label><caption><p><bold>Evolution of total leucocyte and lymphocyte/neutrophil ratios (L/N) in</bold>
<bold><italic toggle="yes">Capra ib</italic></bold><bold>ex and</bold>
<bold><italic toggle="yes">C. hircus</italic></bold>. Blood was collected on days 0, 7 (only for <italic toggle="yes">C. hircus</italic>), 20, 45, 68 and 90 after conjunctival vaccination on day 0 with <italic toggle="yes">Brucella melitensis</italic> Rev.1 strain. <bold>A</bold>, <bold>C</bold>
<italic toggle="yes">Capra ib</italic>ex and <bold>B</bold>, <bold>D</bold>
<italic toggle="yes">C. hircus</italic>. Vaccinated males and females (black triangles, continuous lines and black circles-dotted lines, respectively), compared with control animals (<bold>A</bold>&#8211;<bold>D</bold>), males and females (empty triangles, continuous lines and empty circles-dotted lines respectively). **<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05; *<italic toggle="yes">P</italic>&#8201;=&#8201;0.02; <sup>#</sup><italic toggle="yes">P</italic>&#8201;=&#8201;0.04.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="13567_2019_717_Fig3_HTML.jpg"/></fig>
</p><p id="Par39">A higher initial lymphocyte to neutrophil (L/N) ratio was observed in ibex females in comparison with female goats (Figure&#160;<xref rid="Fig3" ref-type="fig">3</xref>C), but this was not significant. In vaccinated ibexes, a gradual increase of the L/N ratio was observed between D0 and D68 and was only significant on D68 compared to D0 (in favor of lymphocytes, <italic toggle="yes">P</italic>&#8201;=&#8201;0.04), corresponding to the multiplication of antibody-producing cells (Figures&#160;<xref rid="Fig3" ref-type="fig">3</xref>C and D). In vaccinated goats, a more rapid gradual increase of the L/N ratio was observed between D0 and D20 and was only significant on D20 versus D0 (<italic toggle="yes">P</italic>&#8201;=&#8201;0.02). This response occurred later and with a higher intensity in ibexes compared to goats.</p></sec><sec id="Sec20"><title>Serological response</title><p id="Par40">Changes in serological response after vaccination in both RBT and CFT are shown in Tables&#160;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. Significant effects of day of sampling were observed for both CFT titers and RBT scores, with maximum values reached 20 and 45&#160;days pv for RBT and CFT, respectively (3.6&#8201;&#177;&#8201;0.2 and 973&#8201;&#177;&#8201;187 ICFTU/mL). As expected, all animals showed seroconversion within 45&#160;days pv [<xref ref-type="bibr" rid="CR48">48</xref>] (Figures&#160;<xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>). However, the serological response (RBT score and CFT titers) was more intense and persistent in ibexes than in goats, with differences averaging 920&#8201;&#177;&#8201;257 ICFTU/mL and 1.5&#8201;&#177;&#8201;0.19 for RBT and CFT, respectively (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.0001). The presence of bacteremia increased the antibody response observed with RBT. All ibexes remained seropositive throughout the experiment (with RBT- and CFT-positive results), whereas only one goat remained seropositive on day 90&#160;pv as described in Ponsart et al. [<xref ref-type="bibr" rid="CR48">48</xref>]).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p><bold>Simultaneous tests for general linear hypotheses explaining RBT score and CFT titers (Lmer4 package, animal considered as random effect)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Fixed effects</th><th align="left" rowspan="2" colspan="1">Level</th><th align="left" colspan="3" rowspan="1">CFT titers (ICFTU/mL)</th><th align="left" colspan="3" rowspan="1">RBT score</th></tr><tr><th align="left" colspan="1" rowspan="1">Estimate&#8201;&#177;&#8201;standard error</th><th align="left" colspan="1" rowspan="1">z value</th><th align="left" colspan="1" rowspan="1">Probability&#8201;&gt;&#8201;|z|</th><th align="left" colspan="1" rowspan="1">Estimate&#8201;&#177;&#8201;standard error</th><th align="left" colspan="1" rowspan="1">z value</th><th align="left" colspan="1" rowspan="1">Probability&#8201;&gt;&#8201;|z|</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Intercept</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">516&#8201;&#177;&#8201;313</td><td char="." align="char" colspan="1" rowspan="1">1.65</td><td char="." align="char" colspan="1" rowspan="1">0.09</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">1.5&#8201;&#177;&#8201;0.3</td><td char="." align="char" colspan="1" rowspan="1">6.0</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr><tr><td align="left" rowspan="5" colspan="1">Day of sampling pv</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">449&#8201;&#177;&#8201;187</td><td char="." align="char" colspan="1" rowspan="1">2.4</td><td char="." align="char" colspan="1" rowspan="1">0.02</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">3.6&#8201;&#177;&#8201;0.2</td><td char="." align="char" colspan="1" rowspan="1">19.4</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">45</td><td align="left" colspan="1" rowspan="1">973&#8201;&#177;&#8201;187</td><td char="." align="char" colspan="1" rowspan="1">5.2</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">3.6&#8201;&#177;&#8201;0.2</td><td char="." align="char" colspan="1" rowspan="1">19.4</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">68</td><td align="left" colspan="1" rowspan="1">863.1&#8201;&#177;&#8201;239</td><td char="." align="char" colspan="1" rowspan="1">3.6</td><td char="." align="char" colspan="1" rowspan="1">0.0003</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">3.4&#8201;&#177;&#8201;0.2</td><td char="." align="char" colspan="1" rowspan="1">14.7</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">90</td><td align="left" colspan="1" rowspan="1">460&#8201;&#177;&#8201;239</td><td char="." align="char" colspan="1" rowspan="1">1.9</td><td char="." align="char" colspan="1" rowspan="1">0.05</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">3.0&#8201;&#177;&#8201;0.2</td><td char="." align="char" colspan="1" rowspan="1">13.1</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr><tr><td align="left" rowspan="2" colspan="1">Species</td><td align="left" colspan="1" rowspan="1">Goat</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Ibex</td><td align="left" colspan="1" rowspan="1">920&#8201;&#177;&#8201;257</td><td char="." align="char" colspan="1" rowspan="1">3.6</td><td char="." align="char" colspan="1" rowspan="1">0.0003</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">1.5&#8201;&#177;&#8201;0.19</td><td char="." align="char" colspan="1" rowspan="1">7.7</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr><tr><td align="left" rowspan="2" colspan="1">Bacteremia 20&#160;days pv</td><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">128&#8201;&#177;&#8201;273</td><td char="." align="char" colspan="1" rowspan="1">0.5</td><td char="." align="char" colspan="1" rowspan="1">&gt;&#8201;0.05</td><td char="&#xB1;" align="char" colspan="1" rowspan="1">1.2&#8201;&#177;&#8201;0.2</td><td char="." align="char" colspan="1" rowspan="1">5.9</td><td char="." align="char" colspan="1" rowspan="1">&lt;&#8201;0.0001</td></tr></tbody></table></table-wrap>
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table&#160;4</label><caption><p><bold>Mean CFT titers (mean titer&#8201;&#177;&#8201;SEM; CFT) and number of goats and ibexes positive in Rose Bengal tests (RBT) from 20 to 90</bold>&#160;<bold>days after conjunctival vaccination with</bold>
<bold><italic toggle="yes">Brucella melitensis</italic></bold>
<bold>Rev.1 strain (all samples were negative at D0 in both tests)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Group</th><th align="left" colspan="2" rowspan="1">D20</th><th align="left" colspan="2" rowspan="1">D45</th><th align="left" colspan="2" rowspan="1">D68</th><th align="left" colspan="2" rowspan="1">D90</th></tr><tr><th align="left" colspan="1" rowspan="1">CF</th><th align="left" colspan="1" rowspan="1">RBT</th><th align="left" colspan="1" rowspan="1">CF</th><th align="left" colspan="1" rowspan="1">RBT</th><th align="left" colspan="1" rowspan="1">CF</th><th align="left" colspan="1" rowspan="1">RBT</th><th align="left" colspan="1" rowspan="1">CF</th><th align="left" colspan="1" rowspan="1">RBT</th></tr></thead><tbody><tr><td align="left" colspan="9" rowspan="1">Necropsied on D45</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vaccinated ibex (5)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">810&#8201;&#177;&#8201;397</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">1984&#8201;&#177;&#8201;1048</td><td align="left" colspan="1" rowspan="1">55</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Control ibex (1)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vaccinated goats (4)</td><td align="left" colspan="1" rowspan="1">322&#8201;&#177;&#8201;432</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">82&#8201;&#177;&#8201;61</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Control goats (0)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="9" rowspan="1">Necropsied on D90</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vaccinated ibex (4)</td><td align="left" colspan="1" rowspan="1">527&#8201;&#177;&#8201;440</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">1493&#8201;&#177;&#8201;708</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">1573&#8201;&#177;&#8201;646</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">773&#8201;&#177;&#8201;305</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Control ibex (2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0 vs. 160*</td><td align="left" colspan="1" rowspan="1">1<sup>b</sup></td><td align="left" colspan="1" rowspan="1">0 vs. 160*</td><td align="left" colspan="1" rowspan="1">1<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vaccinated goats (4)</td><td align="left" colspan="1" rowspan="1">45&#8201;&#177;&#8201;39</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">78&#8201;&#177;&#8201;63</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">25&#8201;&#177;&#8201;15</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">20&#8201;&#177;&#8201;35</td><td align="left" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Control goats (2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">0</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Number of animals per group.</p><p><sup>b</sup>One male control ibex presented a seroconversion on day 68.</p><p>*Corresponding to the unvaccinated Ibex second control seroconversion.</p></table-wrap-foot></table-wrap>
<fig id="Fig4" position="float" orientation="portrait"><label>Figure&#160;4</label><caption><p><bold>Evolution of CFT titers (ICFTU/mL) and RBT scores in</bold>
<bold><italic toggle="yes">Capra hircus</italic></bold>. <bold>A</bold> Vaccinated goats, necropsied 45&#160;days post-vaccination, and <bold>B</bold> vaccinated and control goats both necropsied 90&#160;days post-vaccination. Titers and scores were obtained on days 0, 20, 45, 68 and 90 after conjunctival vaccination on day 0 with <italic toggle="yes">B. melitensis</italic> Rev.1 strain, in both males (M) and females (F) (squares continuous lines for CFT titers and respectively diamonds in dotted lines for RBT score).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="13567_2019_717_Fig4_HTML.jpg"/></fig>
<fig id="Fig5" position="float" orientation="portrait"><label>Figure&#160;5</label><caption><p><bold>Evolution of CFT titers (ICFTU/mL) and RBT scores in</bold>
<bold><italic toggle="yes">Capra ibex</italic></bold>. <bold>A</bold> Vaccinated ibexes and control ibex (identified 2349) necropsied 45&#160;days post-vaccination, and <bold>B</bold> vaccinated and control ibexes (identified 1926 and 1895) necropsied 90&#160;days post-vaccination. Titers and scores were obtained on days 0, 20, 45, 68 and 90 after conjunctival vaccination on day 0 with <italic toggle="yes">Brucella melitensis</italic> Rev.1 strain, in both males (M) and females (F) (squares continuous lines for CFT titers and respectively diamonds in dotted lines for RBT score).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO5" position="float" orientation="portrait" xlink:href="13567_2019_717_Fig5_HTML.jpg"/></fig>
</p></sec><sec id="Sec21"><title>Kinetics and distribution of the <italic toggle="yes">B. melitensis</italic> Rev.1 vaccine</title><p id="Par41">In total, 375 bacteriological samples were analyzed from the 22 animals that survived more than 20&#160;days pv (i.e., 10 goats and 12 ibexes, 17 vaccinated and 5 unvaccinated). Of these 375 samples, 94 were found to be culture-positive [<xref ref-type="bibr" rid="CR48">48</xref>]. All vaccinated animals exhibited at least one positive culture, all being positive at the time of necropsy in the head region, irrespective of the species or time post-vaccination (local initial multiplication). Furthermore, the contact ibex male was found to be infected by the Rev.1 strain (6 from 11 examined organs being culture-positive), while the four other contacts (one female and one male goat, two female ibexes) were found negative at the time of necropsy.</p><p id="Par42">The proportion of culture-positive organs was studied among 50 sampling*individual events collected in vivo or at the time of necropsy among 17 vaccinated animals. Significant effects of time pv, of mode of sampling, and of species were observed, but there was no significant effect of animal gender (this was not retained in the best model according to the AIC model values). The probability of observing positive results was logically much lower during in vivo sampling compared to necropsy time (OR<sub>in vivo/necropsy</sub>&#8201;=&#8201;0.037, 95% CI [0.005; 0.289]). As expected, based on a previous study, this probability was also lower at day 90 pv compared to day 45 pv (OR<sub>90 versus 45</sub>&#8201;=&#8201;0.091, 95% CI [0.010; 0.860]). The proportion of culture-positive organs was higher in the ibexes compared to the domestic goats (OR<sub>ibex/goat</sub>&#8201;=&#8201;4.184, 95% CI [2.311; 7.574]). When focusing the analysis on the organs from the pelvic region, the species effect was again the most important factor (OR<sub>ibex/goat</sub>&#8201;=&#8201;7.222, 95% CI [2.192; 23.799]), and the mode of sampling was still significant (OR<sub>in vivo/necropsy</sub>&#8201;=&#8201;0.154, 95% CI [0.032; 0.733]), while the period had no significant effect.</p><p id="Par43">In ibexes, average Rev.1 burdens in infected organs ranged from 1 to 300 on day 45&#160;pv and from 1 to 100 at day 90&#160;pv. In goats, average Rev.1 burdens ranged from 1 to 30 on day 45&#160;pv and from 1 to 10 on day 90&#160;pv. The bacterial burden (log-transformed) was studied for culture-positive organs examined at necropsy among 17 vaccinated individuals (either necropsied 45 or 90&#160;days pv). Significant effects of time of necropsy (45 or 90&#160;pv), of organ type, and species were observed, but there was no significant influence of animal gender. The bacterial burden was significantly lower in the head swabs (ocular or nasal) compared to any other organs, including genital and bladder swabs (<italic toggle="yes">P</italic><sub>Ex_head/Ex_genital</sub>&#8201;=&#8201;&#8722;4.876, 95% CI [&#8722;8.229; &#8722;1.523]). The bacterial burden was found to be about 10 times lower 90&#160;days pv compared to 45&#160;days pv (<italic toggle="yes">P</italic><sub>90 vs 45</sub>&#8201;=&#8201;&#8722;2.167<xref ref-type="fn" rid="Fn1">1</xref>, 95% CI [&#8722;3.145; &#8722;1.188]). The bacterial burden of the culture-positive organs was also at least 10 times higher in ibexes compared to goats (<italic toggle="yes">P</italic><sub>ibex/goat</sub>&#8201;=&#8201;+&#8201;2.410 (see Footnote 1), 95% CI [+&#8201;1.409; 3.411]). The interaction between the period and the species was not significant.</p></sec><sec id="Sec22"><title>Bacterial analyses in animal litter</title><p id="Par45">None of the manure samples collected 68&#160;days pv revealed the presence of <italic toggle="yes">Brucella</italic> (DNA detection and bacteria isolation). The efficiency and the sensitivity of both methods were comprised between 10<sup>2</sup> and 10<sup>4</sup>&#160;CFU/g using the <italic toggle="yes">B. melitensis</italic> reference strain (data not shown).</p></sec></sec><sec id="Sec23"><title>Discussion</title><p id="Par46">As expected during a successful Rev.1 vaccination, all vaccinated animals seroconverted and exhibited loco-regional Rev.1 strain multiplication. None of these vaccinated animals developed detectable lesions nor clinical signs attributable to the Rev.1 vaccine [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. However, contrary to the experts&#8217; expectations, our results revealed a highly contrasting vaccine outcome between the two species, which invalidated the hypothesis of comparable innocuousness of the Rev.1 vaccine between the Alpine ibex and the domestic goat.</p><sec id="Sec24"><title>Rev.1 distribution and burden in Alpine ibex and domestic goat</title><p id="Par47">The proportion of Rev.1-infected samples and the bacterial burdens observed in culture-positive organs were significantly higher in ibexes compared to goats. In goats, vaccination is likely to give rise to a bacteremia and a generalized infection [<xref ref-type="bibr" rid="CR50">50</xref>]. Elberg and Meyer [<xref ref-type="bibr" rid="CR51">51</xref>] showed that tissues of subcutaneous vaccinated goats have practically cleared themselves of Rev.1 vaccine by 14&#160;weeks post-vaccination, a duration which is shortened through vaccination by the conjunctival route [<xref ref-type="bibr" rid="CR51">51</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref>]. In this experiment, differences between species were the dominant factor, with negligible effects of individual factors such as gender. The proportion of infected organs, both at the whole individual level or focusing on the pelvic organs, decreased over time but remained moderate at 90&#160;days pv in both species, with considerable individual variability. These results suggest a higher risk of Rev.1 shedding between day 20 and day 68 in ibex, but given the positive culture observed on day 90 pv, it is not possible to rule out potential persistence and shedding in the long term in vaccinated ibexes (or goats [<xref ref-type="bibr" rid="CR19">19</xref>]). Sparse data have been published on vaccination of adult non-pregnant female deer. However, prolonged serological responses [<xref ref-type="bibr" rid="CR54">54</xref>], as well as milk excretion, [<xref ref-type="bibr" rid="CR22">22</xref>] have been reported, supporting the hypothesis of possible systemic infection. Two vaccinated male ibexes presented urogenital excretion 20, 45 or 68&#160;days pv, which was not observed in the other vaccinated batches. As a logical consequence, the control male ibex sharing the same box seroconverted between 45 and 68 pv and exhibited a similar Rev.1 burden to its vaccinated fellows when necropsied 90&#160;days pv. It has been previously shown that the persistence of Rev.1 in vaccinated goats on the conjunctiva, and in nasal secretion as well in the saliva is weakly detectable up to 15&#160;days post vaccination [<xref ref-type="bibr" rid="CR19">19</xref>]. This local scattering had no effect on sentinel goats (swabs and serology remained negative) indicating that there was no contamination by the vaccine strain (I. Jacques, personal communication). In Portugal, a study reported that sentinel animals remained negative in serology when placed with goats vaccinated by Rev.1 [<xref ref-type="bibr" rid="CR55">55</xref>]. Given that no live bacteria were found in animal litter, and the low resistance of the Rev.1 vaccine to ultraviolet exposure, impacting its DNA repair mechanisms [<xref ref-type="bibr" rid="CR56">56</xref>], one may presume that the sentinel male ibex infection was favored by the close contact with vaccinated males sharing the same box. The A1 housing used here is obviously not a comparable situation to the natural environment, where Rev.1 survival is certainly impaired by adverse environmental conditions (temperature, ultraviolet light, etc.). Nevertheless, the distribution of Rev.1 suggests a far lower ability of Alpine ibex to control Rev.1 multiplication, and a higher risk of Rev.1 shedding and further transmission to control individuals than in domestic species. Given this discrepancy, it is also very difficult to assess vaccine efficacy in Alpine ibex based on experiments done in domestic species; we may even hypothesize logical higher susceptibility of Alpine ibex to side effects such as abortions. Differences in vaccine effects in wild and domestic species have been observed, particularly in the American bison (<italic toggle="yes">Bison bison</italic>) and elk (<italic toggle="yes">Cervus canadensis</italic>) regarding <italic toggle="yes">B. abortus</italic> [<xref ref-type="bibr" rid="CR57">57</xref>]. These American-native species were found to be more susceptible to abortion caused by attenuated live-vaccine than the domestic cow (<italic toggle="yes">Bos taurus</italic>) imported from Europe [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In the case of the Alpine ibex, we may hypothesize that its remote and sparse historical distribution [<xref ref-type="bibr" rid="CR58">58</xref>] resulted in limited co-evolution with livestock pathogens including <italic toggle="yes">Brucella</italic>. In addition, intensively hunted Alpine ibex almost became extinct during the nineteenth century, and its recent restauration has been based on small animal numbers [<xref ref-type="bibr" rid="CR59">59</xref>]. This historical background may have resulted in genetic bottleneck events and a consecutive decrease in immune capacity [<xref ref-type="bibr" rid="CR60">60</xref>]. Further studies are clearly required to investigate these hypotheses and the mechanisms for species resistance regarding <italic toggle="yes">Brucella</italic> infection.</p></sec><sec id="Sec25"><title>Immune response</title><p id="Par48">An important result of this experiment concerns the intensity of the highly contrasted immune reaction between the two species. This differentiated dynamic between goats and ibexes may reflect different immune response mechanisms between the two species. The <italic toggle="yes">Brucellae</italic> are intracellular bacteria that elicit both humoral and cell-mediated immune response. The S-LPS <italic toggle="yes">Brucella</italic> major antigen elicits a T-cell dependent immune response with IgG1 dominating. The switch between IgM and IgG occurs in less than 7&#160;days in adults implying that the detection of the early humoral response mainly relies on IgG [<xref ref-type="bibr" rid="CR61">61</xref>]. Goats vaccinated with the standard dose 1&#8201;&#215;&#8201;10<sup>9</sup> CFU by the conjunctival route showed a weak and short humoral response, negative after 4&#160;months [<xref ref-type="bibr" rid="CR49">49</xref>]. However, the antibody response is mostly more significant in adults than in immature animals [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. In this study, humoral response was more intense and prolonged in ibexes compared to goats on the basis of RBT and CFT, with persistent positive results in all ibexes until the end of the experiment. White cell counts exhibited a similar trend: an increase in the production of lymphocytes at the expense of neutrophils later, and that was more intense and lasting in ibexes compared to goats. Recently, a stronger pro-inflammatory response has been observed in <italic toggle="yes">B. melitensis</italic> 16&#160;M-infected pregnant goats compared to Rev.1 at day 28 post-infection together with a greater rise in mononuclear numbers, thus highlighting impacts of strain attenuation on cell-mediated immune response in goats [<xref ref-type="bibr" rid="CR50">50</xref>]. The development of the immune response to <italic toggle="yes">Brucella</italic> infection is not well documented in ibex, even though the high CFT titers observed in the Bargy area&#8217;s ibexes suggest a stronger and longer serological response in ibex naturally infected by <italic toggle="yes">B. melitensis</italic> biovar 3 compared to the domestic species infected by the same strain [<xref ref-type="bibr" rid="CR47">47</xref>]. This study represents, to our knowledge, the first observation of longitudinal monitoring of seroconversion on this species following contact with a <italic toggle="yes">B. melitensis</italic> strain and over a duration of 3&#160;months.</p><p id="Par49">To conclude, the antibody dynamics support the evidence of different immune responses to the Rev.1 vaccine between the Alpine ibex and the domestic goat, with ibexes investing far more in humoral response than goats. In spite of this seemingly stronger immune response, the ibex seems much less effective than the goat in containing the multiplication of this intracellular bacterial strain. Comparable strong antibody responses have previously been reported in elk vaccinated with RB51, together with prolonged bacteremia and slower detectable proliferative responses in PBMC when compared to responses in cattle or bison [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Protection against <italic toggle="yes">Brucella,</italic> as an intracellular pathogen, is believed to be mainly associated with Th1-type cell response, and the subsequent activation of cytotoxic T cells, NK cells, and macrophages [<xref ref-type="bibr" rid="CR64">64</xref>]. In comparison, cytokines associated with a Th2-type response can stimulate antibody responses but can also have negative regulatory effects on Th1-type responses [<xref ref-type="bibr" rid="CR65">65</xref>]. In the elk species, despite robust antibody responses to <italic toggle="yes">Brucella</italic>, the Th1&#8211;Th2 paradigm was the main hypothesis to explain the lack of cellular immune responses and associated reductions in vaccine protection [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Our results lead to similar hypotheses in the ibex species. This might correspond to a &#8220;na&#239;ve&#8221; immune response in wild species, possibly because they did not co-evolve with <italic toggle="yes">Brucella</italic>, unlike domestic ruminant species, and/or to an intrinsic lower immune capacity regarding this pathogen. Further studies are required to better understand immune responses in wild and domestic ruminant species regarding <italic toggle="yes">Brucella</italic>, and their involvement in disease development and shedding outcomes.</p><p id="Par50">In conclusion, tissue localization, shedding of bacteria, and humoral immune responses differ between Alpine ibexes and goats after conjunctival vaccination with <italic toggle="yes">B. melitensis</italic> Rev.1 strain. Ibex expressed more intense and prolonged humoral immune response than the domestic goat, whereas the distribution and organ burdens of the vaccine strain were at least 10 times higher in ibex, particularly in the urogenital organs. Two out of five vaccinated male ibexes shed Rev.1 during the experiment, which resulted in the transmission of Rev.1 to the control male and its seroconversion. Alpine ibexes showed a lower capacity to contain the Rev.1 live-vaccine than the domestic species, and thus represent a higher risk of vaccine strain shedding. The practical constraints associated with the use of the vaccine <italic toggle="yes">in natura</italic> i.e., vaccination only possible in captured ibexes in the spring, including pregnant females, are likely to worsen the excretion of vaccine strain spread, with potentially disruptive effects on the monitoring and management of this wild reservoir. This study focused on the vaccine&#8217;s innocuousness and not on its efficacy or field deployment; therefore, our conclusion is not definitive concerning vaccine use <italic toggle="yes">in natura</italic>, but could contribute to ongoing risk assessment and research addressing the efficacy of disease management strategies.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BTV</term><def><p id="Par2">Blue Tongue Virus (Ovine Catarrhal Fever)</p></def></def-item><def-item><term>BVD</term><def><p id="Par3">bovine viral diarrhea</p></def></def-item><def-item><term>CAEV</term><def><p id="Par4">caprine arthritis encephalitis virus</p></def></def-item><def-item><term>CFT</term><def><p id="Par5">complement fixation test</p></def></def-item><def-item><term>ELISA</term><def><p id="Par6">Enzyme-Linked ImmunoSorbent Assay</p></def></def-item><def-item><term>PBS</term><def><p id="Par7">phosphate buffered saline</p></def></def-item><def-item><term>PBMC</term><def><p id="Par8">peripheral blood mononuclear cell</p></def></def-item><def-item><term>pv</term><def><p id="Par9">post-vaccination</p></def></def-item><def-item><term>QF</term><def><p id="Par10">Q fever</p></def></def-item><def-item><term>RBT</term><def><p id="Par11">Rose Bengal test</p></def></def-item></def-list></glossary><fn-group><fn id="Fn1"><label>1</label><p id="Par44">The data have been log-transformed; please consider the parameter on the log-scale.</p></fn><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Claire Ponsart, Micka&#235;l Riou, Yann Locatelli, Isabelle Jacques and Sophie Rossi contributed equally to this work</p></fn></fn-group><ack><title>Acknowledgements</title><p>This study was supported and funded by the French Directorate General for Food (DGAL), Ministry of Agriculture and Food (Grant No. 020602002001, 2017-104, France) and the Ministry for an Ecological and Solidary Transition (Grant No. 2102054258, France). The authors want to thank the technicians and researchers from the Zoological Park of Haute Touche, INRA, ANSES, the technicians and scientists of Laboratoire de Touraine (in particular Jos&#233; Delaval (Director) and the technical microbiology staff) and the French Wildlife and Hunting Agency (ONCFS) for their contribution to this study. Many thanks to the directors of the Experimental Infectiology Platform, the &#8220;Centre international des ressources microbiennes: bact&#233;ries pathog&#232;nes&#8221; (CIRM-BP) and to the zootechnical staff of the PFIE (Nouzilly, France) and of RZHT (Obterre, France). Due acknowledgments to Dr Nathalie Pozzi, deputy director of Laboratoire National de Contr&#244;le des Reproducteurs (LNCR) and her technical staff (Maisons-Alfort, France) and S&#233;bastien Lambert for his very kind review.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>Design of study and experiments: SR, YL, CP, IJ, BGB, MR, PS, JYC. Planning of animal care and experiments: SR, YL, CP, IJ, BGB, MR. Carrying out of animal experiments: SR, CP, MR, IJ, YL, RS, SB, TC, BB, KO, CV. Carrying out of laboratory assays: SR, CP, MR, IJ, YL, AF, JDL, MJ, LP, LF, DR, EQ. Analysis of results and interpretation of data: SR, YL, CP, IJ, BGB, MR. Statistical analysis: SR, YL, CP, MR. Drafting of the manuscript and revising: SR, YL, CP, IJ, BGB, MR. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par51">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">World animal health information database (WAHIS Interface) (2018) Terrestrial <italic toggle="yes">Brucella melitensis</italic> brucellosis in domestic and wild animals. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/Diseasedistributionmap/index/newlang/en">https://www.oie.int/wahis_2/public/wahid.php/Diseaseinformation/Diseasedistributionmap/index/newlang/en</ext-link>. Accessed 04 Dec 2018</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Plommet</surname><given-names>M</given-names></name></person-group><article-title><italic toggle="yes">B. melitensis</italic> infection in cattle</article-title><source><italic toggle="yes">Brucella melitensis</italic></source><year>1985</year><publisher-loc>Leiden</publisher-loc><publisher-name>Martinus Nijhoff Publishers D</publisher-name><fpage>197</fpage><lpage>203</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alton</surname><given-names>GG</given-names></name></person-group><article-title>Control of <italic toggle="yes">Brucella melitensis</italic> infection in sheep and goats&#8212;a review</article-title><source>Trop Anim Health Prod</source><year>1987</year><volume>19</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1007/BF02297320</pub-id><pub-id pub-id-type="pmid">3307078</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bosseray</surname><given-names>N</given-names></name></person-group><article-title><italic toggle="yes">Brucella melitensis</italic> Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice</article-title><source>Biologicals</source><year>1991</year><volume>19</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/S1045-1056(05)80025-9</pub-id><pub-id pub-id-type="pmid">1797046</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>A review of the use of <italic toggle="yes">B. melitensis</italic> Rev 1 vaccine in adult sheep and goats</article-title><source>Prev Vet Med</source><year>1997</year><volume>31</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/S0167-5877(96)01110-5</pub-id><pub-id pub-id-type="pmid">9234451</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfroid</surname><given-names>J</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Saegerman</surname><given-names>C</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Brucellosis in terrestrial wildlife</article-title><source>Rev Sci Tech</source><year>2013</year><volume>32</volume><fpage>27</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.20506/rst.32.1.2180</pub-id><pub-id pub-id-type="pmid">23837363</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">EFSA and ECDC European food safety authority ECFDPAC (2015) The european union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2013, p 162<pub-id pub-id-type="doi" assigning-authority="pmc">10.2903/j.efsa.2018.5500</pub-id><pub-id pub-id-type="pmcid">PMC7009540</pub-id><pub-id pub-id-type="pmid">32625785</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mailles</surname><given-names>A</given-names></name><name name-style="western"><surname>Rautureau</surname><given-names>S</given-names></name><name name-style="western"><surname>Le Horgne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Poignet-Leroux</surname><given-names>B</given-names></name><name name-style="western"><surname>d&#8217;Arnoux</surname><given-names>C</given-names></name><name name-style="western"><surname>Dennetiere</surname><given-names>G</given-names></name><name name-style="western"><surname>Faure</surname><given-names>M</given-names></name><name name-style="western"><surname>Lavigne</surname><given-names>JP</given-names></name><name name-style="western"><surname>Bru</surname><given-names>JP</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>Re-emergence of brucellosis in cattle in France and risk for human health</article-title><source>Euro Surveill</source><year>2012</year><volume>17</volume><fpage>20227</fpage><pub-id pub-id-type="pmid">22856510</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Hars</surname><given-names>J</given-names></name><name name-style="western"><surname>Drapeau</surname><given-names>A</given-names></name><name name-style="western"><surname>Cherfa</surname><given-names>MA</given-names></name><name name-style="western"><surname>Game</surname><given-names>Y</given-names></name><name name-style="western"><surname>Le Horgne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Rautureau</surname><given-names>S</given-names></name><name name-style="western"><surname>Maucci</surname><given-names>E</given-names></name><name name-style="western"><surname>Pasquier</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Jay</surname><given-names>M</given-names></name><name name-style="western"><surname>Mick</surname><given-names>V</given-names></name></person-group><article-title>Reemergence of <italic toggle="yes">Brucella melitensis</italic> in wildlife, France</article-title><source>Emerg Infect Dis</source><year>2014</year><volume>20</volume><fpage>1570</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.3201/eid2009.131517</pub-id><pub-id pub-id-type="pmid">25152274</pub-id><pub-id pub-id-type="pmcid">PMC4178400</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mick</surname><given-names>V</given-names></name><name name-style="western"><surname>Le Carrou</surname><given-names>G</given-names></name><name name-style="western"><surname>Corde</surname><given-names>Y</given-names></name><name name-style="western"><surname>Game</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jay</surname><given-names>M</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title><italic toggle="yes">Brucella melitensis</italic> in France: persistence in wildlife and probable spillover from Alpine <italic toggle="yes">ibex</italic> to domestic animals</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e94168</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0094168</pub-id><pub-id pub-id-type="pmid">24732322</pub-id><pub-id pub-id-type="pmcid">PMC3986073</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hars</surname><given-names>J</given-names></name><name name-style="western"><surname>Vaniscotte</surname><given-names>A</given-names></name><name name-style="western"><surname>Game</surname><given-names>Y</given-names></name><name name-style="western"><surname>To&#239;go</surname><given-names>C</given-names></name><name name-style="western"><surname>Depecker</surname><given-names>A</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>Surveillance et gestion d&#8217;un foyer de brucellose chez le bouquetin dans le massif du Bargy (Haute-Savoie)</article-title><source>Faune sauvage</source><year>2015</year><volume>306</volume><fpage>11</fpage><lpage>20</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchand</surname><given-names>P</given-names></name><name name-style="western"><surname>Freycon</surname><given-names>P</given-names></name><name name-style="western"><surname>Herbaux</surname><given-names>JP</given-names></name><name name-style="western"><surname>Game</surname><given-names>Y</given-names></name><name name-style="western"><surname>Toigo</surname><given-names>C</given-names></name><name name-style="western"><surname>Gilot-Fromont</surname><given-names>E</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>S</given-names></name><name name-style="western"><surname>Hars</surname><given-names>J</given-names></name></person-group><article-title>Sociospatial structure explains marked variation in brucellosis seroprevalence in an Alpine <italic toggle="yes">ibex</italic> population</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>15592</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-15803-w</pub-id><pub-id pub-id-type="pmid">29142204</pub-id><pub-id pub-id-type="pmcid">PMC5688143</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">ANSES (2015) Mesures de ma&#238;trise de la brucellose chez les bouquetins du Bargy. ANSES, p 194</mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Th&#233;bault A, To&#239;go C, Gaillard J-M, Gauthier D, Vaniscotte A, Garin-Bastuji B, Gani&#232;re J-P, Dufour B, Gilot-Fromont E (2015) First results of modelling brucellosis in a wild population of Alpine <italic toggle="yes">ibex</italic> (<italic toggle="yes">Capra ibex</italic>) under management strategies. In: 23rd meeting of the Alpine Ibex European Specialist Group (GSE&#8211;AIESG)</mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elberg</surname><given-names>SS</given-names></name></person-group><article-title>Rev. 1 <italic toggle="yes">Brucella melitensis</italic> vaccine. Part II, 1968&#8211;1980</article-title><source>Vet Bull</source><year>1981</year><volume>51</volume><fpage>67</fpage><lpage>73</lpage></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elberg</surname><given-names>SS</given-names></name></person-group><article-title>Rev. 1 <italic toggle="yes">Brucella melitensis</italic> vaccine. Part III, 1981&#8211;1995</article-title><source>Vet Bull</source><year>1996</year><volume>66</volume><fpage>1193</fpage><lpage>1200</lpage></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">(OIE) (2016) WHO Brucellosis (<italic toggle="yes">Brucella abortus</italic>, <italic toggle="yes">B. melitensis, B. suis</italic>) and infection with <italic toggle="yes">B. abortus</italic>; <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">B. suis.</italic> In: OIE (ed) Terrestrial animal health manual. p 44</mixed-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munoz</surname><given-names>PM</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Marin</surname><given-names>CM</given-names></name><name name-style="western"><surname>Barberan</surname><given-names>M</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name></person-group><article-title>Immunopathological responses and kinetics of <italic toggle="yes">Brucella melitensis</italic> Rev 1 infection after subcutaneous or conjunctival vaccination in rams</article-title><source>Vaccine</source><year>2008</year><volume>26</volume><fpage>2562</fpage><lpage>2569</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2008.03.030</pub-id><pub-id pub-id-type="pmid">18423950</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zundel</surname><given-names>E</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Michel</surname><given-names>R</given-names></name></person-group><article-title>Conjunctival vaccination of pregnant ewes and goats with <italic toggle="yes">Brucella melitensis</italic> Rev 1 vaccine: safety and serological responses</article-title><source>Ann Rech Vet</source><year>1992</year><volume>23</volume><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">1610080</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banai</surname><given-names>M</given-names></name></person-group><article-title>Control of small ruminant brucellosis by use of <italic toggle="yes">Brucella melitensis</italic> Rev. 1 vaccine: laboratory aspects and field observations</article-title><source>Vet Microbiol</source><year>2002</year><volume>90</volume><fpage>497</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/S0378-1135(02)00231-6</pub-id><pub-id pub-id-type="pmid">12414167</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Banai M, Abramson M, Mayer I, Chechik K, Hoida G, Zamir O, Bardenstein S, Cohen A, Davidson M (1996) Problems associated with the persistence and possible horizontal transfer of <italic toggle="yes">Brucella melitensis</italic> Rev.1 vaccine in connection with serological surveillance in Israel. In: Garin-Bastuji B, Benkirane A (eds) FAO/WHO/OIE round table on the use of Rev.1 vaccine in small ruminants and cattle, pp 69&#8211;76</mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>JL</given-names></name><name name-style="western"><surname>Gonzalez-Juarrero</surname><given-names>M</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>RA</given-names></name></person-group><article-title>Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent <italic toggle="yes">Brucella melitensis</italic> strain 16&#160;M and the reduced virulence vaccine strain Rev. 1</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><fpage>e0185823</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0185823</pub-id><pub-id pub-id-type="pmid">29028813</pub-id><pub-id pub-id-type="pmcid">PMC5640220</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Pang</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name></person-group><article-title>Ontology-based meta-analysis of animal and human adverse events associated with licensed brucellosis vaccines</article-title><source>Front Pharmacol</source><year>2018</year><volume>9</volume><fpage>503</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00503</pub-id><pub-id pub-id-type="pmid">29867505</pub-id><pub-id pub-id-type="pmcid">PMC5962797</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grossen</surname><given-names>C</given-names></name><name name-style="western"><surname>Biebach</surname><given-names>I</given-names></name><name name-style="western"><surname>Angelone-Alasaad</surname><given-names>S</given-names></name><name name-style="western"><surname>Keller</surname><given-names>LF</given-names></name><name name-style="western"><surname>Croll</surname><given-names>D</given-names></name></person-group><article-title>Population genomics analyses of European <italic toggle="yes">ibex</italic> species show lower diversity and higher inbreeding in reintroduced populations</article-title><source>Evol Appl</source><year>2018</year><volume>11</volume><fpage>123</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1111/eva.12490</pub-id><pub-id pub-id-type="pmid">29387150</pub-id><pub-id pub-id-type="pmcid">PMC5775499</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">ONCFS (2016) Rapport d&#8217;appui scientifique et technique pour d&#233;finir et &#233;valuer bibliographiquement les crit&#232;res pr&#233;alables &#224; une approche vaccinale contre la brucellose chez les bouquetins du massif du Bargy, p 29 (in French)</mixed-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Cheville</surname><given-names>NF</given-names></name><name name-style="western"><surname>Kunkle</surname><given-names>RA</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>MV</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>AE</given-names></name></person-group><article-title>Bacterial survival, lymph node pathology, and serological responses of bison (<italic toggle="yes">Bison bison</italic>) vaccinated with <italic toggle="yes">Brucella abortus</italic> strain RB51 or strain 19</article-title><source>J Wildl Dis</source><year>1997</year><volume>33</volume><fpage>146</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.7589/0090-3558-33.1.146</pub-id><pub-id pub-id-type="pmid">9027704</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreeger</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Cook</surname><given-names>WE</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>WH</given-names></name><name name-style="western"><surname>Elzer</surname><given-names>PH</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name></person-group><article-title><italic toggle="yes">Brucella abortus</italic> strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion</article-title><source>J Wildl Dis</source><year>2002</year><volume>38</volume><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.7589/0090-3558-38.1.27</pub-id><pub-id pub-id-type="pmid">11838225</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Christie</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Grainger</surname><given-names>DW</given-names></name><name name-style="western"><surname>Stoffregen</surname><given-names>WS</given-names></name></person-group><article-title>Immunologic responses of bison to vaccination with <italic toggle="yes">Brucella abortus</italic> strain RB51: comparison of parenteral to ballistic delivery via compressed pellets or photopolymerized hydrogels</article-title><source>Vaccine</source><year>2006</year><volume>24</volume><fpage>1346</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2005.09.034</pub-id><pub-id pub-id-type="pmid">16236400</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Fach</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>MV</given-names></name><name name-style="western"><surname>Sacco</surname><given-names>RE</given-names></name><name name-style="western"><surname>Stoffregen</surname><given-names>WC</given-names></name><name name-style="western"><surname>Waters</surname><given-names>WR</given-names></name></person-group><article-title>Immune responses of elk to initial and booster vaccinations with <italic toggle="yes">Brucella abortus</italic> strain RB51 or 19</article-title><source>Clin Vaccine Immunol</source><year>2006</year><volume>13</volume><fpage>1098</fpage><lpage>1103</lpage><pub-id pub-id-type="doi">10.1128/CVI.00213-06</pub-id><pub-id pub-id-type="pmid">17028213</pub-id><pub-id pub-id-type="pmcid">PMC1595328</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name></person-group><article-title>Comparison of abortion and infection after experimental challenge of pregnant bison and cattle with <italic toggle="yes">Brucella abortus</italic> strain 2308</article-title><source>Clin Vaccine Immunol</source><year>2011</year><volume>18</volume><fpage>2075</fpage><lpage>2078</lpage><pub-id pub-id-type="doi">10.1128/CVI.05383-11</pub-id><pub-id pub-id-type="pmid">21976222</pub-id><pub-id pub-id-type="pmcid">PMC3232706</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Institut fran&#231;ais d&#8217;Information juridique (2018) Code Rural et de la P&#234;che Maritime, p 547</mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">PFIE, INRA (2018) Infectiology of farm, model and wild animals facility, 10.15454/1.5572352821559333e12. Accessed 29 Oct 2019</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>N</given-names></name><name name-style="western"><surname>Noakes</surname><given-names>DE</given-names></name></person-group><article-title>Sexual maturity in British breeds of goat kids</article-title><source>Br Vet J</source><year>1996</year><volume>152</volume><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/S0007-1935(96)80089-3</pub-id><pub-id pub-id-type="pmid">8634870</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santiago-Moreno</surname><given-names>J</given-names></name><name name-style="western"><surname>Gomez-Brunet</surname><given-names>A</given-names></name><name name-style="western"><surname>Gonzalez-Bulnes</surname><given-names>A</given-names></name><name name-style="western"><surname>Malpaux</surname><given-names>B</given-names></name><name name-style="western"><surname>Chemineau</surname><given-names>P</given-names></name><name name-style="western"><surname>Pulido-Pastor</surname><given-names>A</given-names></name><name name-style="western"><surname>Lopez-Sebastian</surname><given-names>A</given-names></name></person-group><article-title>Seasonal ovulatory activity and plasma prolactin concentrations in the Spanish <italic toggle="yes">ibex</italic> (<italic toggle="yes">Capra pyrenaica hispanica</italic>) maintained in captivity</article-title><source>Reprod Nutr Dev</source><year>2003</year><volume>43</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1051/rnd:2003023</pub-id><pub-id pub-id-type="pmid">14620629</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Zingg</surname><given-names>R</given-names></name></person-group><article-title>Alpine <italic toggle="yes">ibex</italic> (<italic toggle="yes">Capra ibex ibex</italic>)</article-title><source>Grzimek&#8217;s encyclopedia of mammals</source><year>1990</year><publisher-loc>New York</publisher-loc><publisher-name>McGraw Hill</publisher-name><fpage>516</fpage><lpage>523</lpage></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laloy</surname><given-names>E</given-names></name><name name-style="western"><surname>Breard</surname><given-names>E</given-names></name><name name-style="western"><surname>Trapp</surname><given-names>S</given-names></name><name name-style="western"><surname>Pozzi</surname><given-names>N</given-names></name><name name-style="western"><surname>Riou</surname><given-names>M</given-names></name><name name-style="western"><surname>Barc</surname><given-names>C</given-names></name><name name-style="western"><surname>Breton</surname><given-names>S</given-names></name><name name-style="western"><surname>Delaunay</surname><given-names>R</given-names></name><name name-style="western"><surname>Cordonnier</surname><given-names>N</given-names></name><name name-style="western"><surname>Chateau-Joubert</surname><given-names>S</given-names></name><name name-style="western"><surname>Crochet</surname><given-names>D</given-names></name><name name-style="western"><surname>Gouzil</surname><given-names>J</given-names></name><name name-style="western"><surname>Hebert</surname><given-names>T</given-names></name><name name-style="western"><surname>Raimbourg</surname><given-names>M</given-names></name><name name-style="western"><surname>Viarouge</surname><given-names>C</given-names></name><name name-style="western"><surname>Vitour</surname><given-names>D</given-names></name><name name-style="western"><surname>Durand</surname><given-names>B</given-names></name><name name-style="western"><surname>Ponsart</surname><given-names>C</given-names></name><name name-style="western"><surname>Zientara</surname><given-names>S</given-names></name></person-group><article-title>Fetopathic effects of experimental Schmallenberg virus infection in pregnant goats</article-title><source>Vet Microbiol</source><year>2017</year><volume>211</volume><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2017.10.011</pub-id><pub-id pub-id-type="pmid">29102110</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>A</given-names></name><name name-style="western"><surname>Salle</surname><given-names>G</given-names></name><name name-style="western"><surname>Ballan</surname><given-names>V</given-names></name><name name-style="western"><surname>Reigner</surname><given-names>F</given-names></name><name name-style="western"><surname>Meynadier</surname><given-names>A</given-names></name><name name-style="western"><surname>Cortet</surname><given-names>J</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C</given-names></name><name name-style="western"><surname>Riou</surname><given-names>M</given-names></name><name name-style="western"><surname>Blanchard</surname><given-names>A</given-names></name><name name-style="western"><surname>Mach</surname><given-names>N</given-names></name></person-group><article-title>Strongyle infection and gut microbiota: profiling of resistant and susceptible horses over a grazing season</article-title><source>Front Physiol</source><year>2018</year><volume>9</volume><fpage>272</fpage><pub-id pub-id-type="doi">10.3389/fphys.2018.00272</pub-id><pub-id pub-id-type="pmid">29618989</pub-id><pub-id pub-id-type="pmcid">PMC5871743</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bounaadja</surname><given-names>L</given-names></name><name name-style="western"><surname>Albert</surname><given-names>D</given-names></name><name name-style="western"><surname>Chenais</surname><given-names>B</given-names></name><name name-style="western"><surname>Henault</surname><given-names>S</given-names></name><name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Poliak</surname><given-names>S</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>Real-time PCR for identification of <italic toggle="yes">Brucella</italic> spp.: a comparative study of IS711, bcsp31 and per target genes</article-title><source>Vet Microbiol</source><year>2009</year><volume>137</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2008.12.023</pub-id><pub-id pub-id-type="pmid">19200666</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Alton</surname><given-names>GG</given-names></name><name name-style="western"><surname>Jones</surname><given-names>L</given-names></name><name name-style="western"><surname>Angus</surname><given-names>RD</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name></person-group><source>Techniques for the brucellosis laboratory</source><year>1988</year><publisher-loc>Paris</publisher-loc><publisher-name>INRA Publications</publisher-name><fpage>192</fpage></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lopez-Goni</surname><given-names>I</given-names></name><name name-style="western"><surname>Garcia-Yoldi</surname><given-names>D</given-names></name><name name-style="western"><surname>Marin</surname><given-names>CM</given-names></name><name name-style="western"><surname>de Miguel</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>PM</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>AC</given-names></name><name name-style="western"><surname>Cardoso</surname><given-names>R</given-names></name><name name-style="western"><surname>Correa de Sa</surname><given-names>MI</given-names></name><name name-style="western"><surname>Walravens</surname><given-names>K</given-names></name><name name-style="western"><surname>Albert</surname><given-names>D</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name></person-group><article-title>Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all <italic toggle="yes">Brucella</italic> species, including the vaccine strains</article-title><source>J Clin Microbiol</source><year>2008</year><volume>46</volume><fpage>3484</fpage><lpage>3487</lpage><pub-id pub-id-type="doi">10.1128/JCM.00837-08</pub-id><pub-id pub-id-type="pmid">18716225</pub-id><pub-id pub-id-type="pmcid">PMC2566117</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dohoo</surname><given-names>I</given-names></name><name name-style="western"><surname>Martin</surname><given-names>W</given-names></name><name name-style="western"><surname>Stryhn</surname><given-names>H</given-names></name></person-group><article-title>Mixed models for discrete data</article-title><source>Vet Epidemiol Res</source><year>2009</year><volume>2</volume><fpage>584</fpage><lpage>585</lpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Zuur</surname><given-names>A</given-names></name><name name-style="western"><surname>Leno</surname><given-names>EN</given-names></name><name name-style="western"><surname>Walker</surname><given-names>N</given-names></name><name name-style="western"><surname>Saveliev</surname><given-names>AA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>GM</given-names></name></person-group><source>Mixed effects models and extensions in ecology with R</source><year>2009</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>574</fpage></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Burnham</surname><given-names>KP</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>DR</given-names></name></person-group><source>Model selection and multimodel inference: a practical information-theoretic approach</source><year>2002</year><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>458</fpage></element-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Bates DM, Sarkar D (2007) lme4: linear mixed-effects models using S4 classes. R package version 0.99875&#8211;6</mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Barton K (2009) Mu-MIn: multi-model inference. R package version 0.12.2/r18</mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freycon</surname><given-names>P</given-names></name><name name-style="western"><surname>Game</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hars</surname><given-names>J</given-names></name><name name-style="western"><surname>Gilot</surname><given-names>E</given-names></name></person-group><article-title>Lesional aspects of <italic toggle="yes">Brucella melitensis</italic> in <italic toggle="yes">Capra ibex</italic></article-title><source>Bull Acad Vet France</source><year>2017</year><volume>170</volume><fpage>126</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.4267/2042/62276</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lambert</surname><given-names>S</given-names></name><name name-style="western"><surname>Gilot-Fromont</surname><given-names>E</given-names></name><name name-style="western"><surname>Freycon</surname><given-names>P</given-names></name><name name-style="western"><surname>Thebault</surname><given-names>A</given-names></name><name name-style="western"><surname>Game</surname><given-names>Y</given-names></name><name name-style="western"><surname>Toigo</surname><given-names>C</given-names></name><name name-style="western"><surname>Petit</surname><given-names>E</given-names></name><name name-style="western"><surname>Barthe</surname><given-names>MN</given-names></name><name name-style="western"><surname>Reynaud</surname><given-names>G</given-names></name><name name-style="western"><surname>Jay</surname><given-names>M</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Ponsart</surname><given-names>C</given-names></name><name name-style="western"><surname>Hars</surname><given-names>J</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>S</given-names></name></person-group><article-title>High shedding potential and significant individual heterogeneity in naturally-infected Alpine <italic toggle="yes">ibex</italic> (<italic toggle="yes">Capra ibex</italic>) with <italic toggle="yes">Brucella melitensis</italic></article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><fpage>1065</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2018.01065</pub-id><pub-id pub-id-type="pmid">29892274</pub-id><pub-id pub-id-type="pmcid">PMC5985404</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ponsart</surname><given-names>C</given-names></name><name name-style="western"><surname>Garin-Bastuji</surname><given-names>B</given-names></name><name name-style="western"><surname>Riou</surname><given-names>M</given-names></name><name name-style="western"><surname>Locatelli</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fadeau</surname><given-names>A</given-names></name><name name-style="western"><surname>Ja&#255;</surname><given-names>M</given-names></name><name name-style="western"><surname>Jacques</surname><given-names>I</given-names></name><name name-style="western"><surname>Simon</surname><given-names>R</given-names></name><name name-style="western"><surname>Perrot</surname><given-names>L</given-names></name><name name-style="western"><surname>Freddi</surname><given-names>L</given-names></name><name name-style="western"><surname>Breton</surname><given-names>S</given-names></name><name name-style="western"><surname>Chaumeil</surname><given-names>T</given-names></name><name name-style="western"><surname>Blanc</surname><given-names>B</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>K</given-names></name><name name-style="western"><surname>Rioult</surname><given-names>D</given-names></name><name name-style="western"><surname>Qu&#233;m&#233;r&#233;</surname><given-names>E</given-names></name><name name-style="western"><surname>Sarradin</surname><given-names>P</given-names></name><name name-style="western"><surname>Chollet</surname><given-names>JY</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>S</given-names></name></person-group><article-title>Vaccination anti-brucellique du bouquetin des Alpes (<italic toggle="yes">Capra ibex</italic>), une option pour l&#8217;assainissement du massif du Bargy? Comparaison du niveau d&#8217;innocuit&#233; conjonctivale du vaccin Rev. 1 chez le bouquetin des alpes et la ch&#232;vre domestiques (<italic toggle="yes">Capra hircus</italic>)</article-title><source>Bull Epid&#233;miol et Sant&#233; Animale</source><year>2018</year><volume>74</volume><fpage>25</fpage><lpage>42</lpage></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fensterbank</surname><given-names>R</given-names></name><name name-style="western"><surname>Verger</surname><given-names>JM</given-names></name><name name-style="western"><surname>Grayon</surname><given-names>M</given-names></name></person-group><article-title>Conjunctival vaccination of young goats with <italic toggle="yes">Brucella melitensis</italic> strain Rev 1</article-title><source>Ann Rech Vet</source><year>1987</year><volume>18</volume><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">3451685</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higgins</surname><given-names>JL</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gonzalez-Juarrero</surname><given-names>M</given-names></name></person-group><article-title>Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16&#160;M and the reduced virulence strain Rev. 1</article-title><source>Vet Immunol Immunopathol</source><year>2018</year><volume>202</volume><fpage>74</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2018.06.004</pub-id><pub-id pub-id-type="pmid">30078602</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elberg</surname><given-names>SS</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>KF</given-names></name></person-group><article-title>Immunization of goats against brucellosis. (Summary of the experiments concerning the isolation, properties and behavior of vaccine strain)</article-title><source>An Fac Med Lima</source><year>1959</year><volume>42</volume><fpage>83</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.15381/anales.v42i1.8642</pub-id><pub-id pub-id-type="pmid">13819862</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alton</surname><given-names>GG</given-names></name></person-group><article-title>Rev. 1 <italic toggle="yes">Brucella melitensis</italic> vaccine. Serological reactions in Maltese goats</article-title><source>J Comp Pathol</source><year>1967</year><volume>77</volume><fpage>327</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/0021-9975(67)90042-4</pub-id><pub-id pub-id-type="pmid">5634117</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elberg</surname><given-names>SS</given-names></name><name name-style="western"><surname>Faunce</surname><given-names>K</given-names><suffix>Jr</suffix></name></person-group><article-title>Immunization against <italic toggle="yes">Brucella</italic> infection. VI. Immunity conferred on goats by a nondependent mutant from a streptomycin-dependent mutant strain of <italic toggle="yes">Brucella melitensis</italic></article-title><source>J Bacteriol</source><year>1957</year><volume>73</volume><fpage>211</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">13416171</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jb.73.2.211-217.1957</pub-id><pub-id pub-id-type="pmcid">PMC289776</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stournara</surname><given-names>A</given-names></name><name name-style="western"><surname>Minas</surname><given-names>A</given-names></name><name name-style="western"><surname>Bourtzi-Chatzopoulou</surname><given-names>E</given-names></name><name name-style="western"><surname>Stack</surname><given-names>J</given-names></name><name name-style="western"><surname>Koptopoulos</surname><given-names>G</given-names></name><name name-style="western"><surname>Petridou</surname><given-names>E</given-names></name><name name-style="western"><surname>Sarris</surname><given-names>K</given-names></name></person-group><article-title>Assessment of serological response of young and adult sheep to conjunctival vaccination with Rev-1 vaccine by fluorescence polarization assay (FPA) and other serological tests for <italic toggle="yes">B. melitensis</italic></article-title><source>Vet Microbiol</source><year>2007</year><volume>119</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2006.08.004</pub-id><pub-id pub-id-type="pmid">16973307</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meireles</surname><given-names>ML</given-names></name><name name-style="western"><surname>Afonso</surname><given-names>JC</given-names></name><name name-style="western"><surname>Texeira</surname><given-names>M</given-names></name><name name-style="western"><surname>Pires</surname><given-names>FC</given-names></name></person-group><article-title>Prophylaxie de la brucellose caprine au Portugal. Essai du vaccin Rev. 1</article-title><source>Bull Off Int Epizoot</source><year>1974</year><volume>82</volume><fpage>25</fpage><lpage>36</lpage></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Mariri</surname><given-names>A</given-names></name></person-group><article-title>Ultraviolet C lethal effect on <italic toggle="yes">Brucella melitensis</italic></article-title><source>New Microbiol</source><year>2008</year><volume>31</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">18437841</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>National Academies of Sciences E</collab></person-group><source>Medicine revisiting Brucellosis in the Greater Yellowstone Area</source><year>2017</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>The National Academies Press</publisher-name><pub-id pub-id-type="pmid">33433968</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gauthier</surname><given-names>D</given-names></name><name name-style="western"><surname>Martinot</surname><given-names>JP</given-names></name><name name-style="western"><surname>Choisy</surname><given-names>JP</given-names></name><name name-style="western"><surname>Michallet</surname><given-names>J</given-names></name><name name-style="western"><surname>Villaret</surname><given-names>JC</given-names></name><name name-style="western"><surname>Faure</surname><given-names>E</given-names></name></person-group><article-title>Le bouquetin des Alpes</article-title><source>Rev Ecol</source><year>1991</year><volume>46</volume><fpage>233</fpage><lpage>275</lpage></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gauthier</surname><given-names>D</given-names></name><name name-style="western"><surname>Villaret</surname><given-names>JC</given-names></name></person-group><article-title>La r&#233;introduction en France du bouquetin des Alpes</article-title><source>Rev Ecol</source><year>1990</year><volume>45</volume><fpage>97</fpage><lpage>120</lpage></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maudet</surname><given-names>C</given-names></name><name name-style="western"><surname>Miller</surname><given-names>C</given-names></name><name name-style="western"><surname>Bassano</surname><given-names>B</given-names></name><name name-style="western"><surname>Breitenmoser-Wursten</surname><given-names>C</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>D</given-names></name><name name-style="western"><surname>Obexer-Ruff</surname><given-names>G</given-names></name><name name-style="western"><surname>Michallet</surname><given-names>J</given-names></name><name name-style="western"><surname>Taberlet</surname><given-names>P</given-names></name><name name-style="western"><surname>Luikart</surname><given-names>G</given-names></name></person-group><article-title>Microsatellite DNA and recent statistical methods in wildlife conservation management: applications in Alpine <italic toggle="yes">ibex</italic> [<italic toggle="yes">Capra ibex</italic>(<italic toggle="yes">ibex</italic>)]</article-title><source>Mol Ecol</source><year>2002</year><volume>11</volume><fpage>421</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1046/j.0962-1083.2001.01451.x</pub-id><pub-id pub-id-type="pmid">11928708</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ducrotoy</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Conde-Alvarez</surname><given-names>R</given-names></name><name name-style="western"><surname>Blasco</surname><given-names>JM</given-names></name><name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name></person-group><article-title>A review of the basis of the immunological diagnosis of ruminant brucellosis</article-title><source>Vet Immunol Immunopathol</source><year>2016</year><volume>171</volume><fpage>81</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2016.02.002</pub-id><pub-id pub-id-type="pmid">26964721</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kreeger</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Schultz</surname><given-names>W</given-names></name></person-group><article-title>Immune responses of bison to ballistic or hand vaccination with <italic toggle="yes">Brucella abortus</italic> strain RB51</article-title><source>J Wildl Dis</source><year>2002</year><volume>38</volume><fpage>738</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.7589/0090-3558-38.4.738</pub-id><pub-id pub-id-type="pmid">12528440</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kreeger</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>MV</given-names></name></person-group><article-title>Immune responses of elk to vaccination with <italic toggle="yes">Brucella abortus</italic> strain RB51</article-title><source>J Wildl Dis</source><year>2002</year><volume>38</volume><fpage>746</fpage><lpage>751</lpage><pub-id pub-id-type="doi">10.7589/0090-3558-38.4.746</pub-id><pub-id pub-id-type="pmid">12528441</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorneles</surname><given-names>EMS</given-names></name><name name-style="western"><surname>Oliveria</surname><given-names>LF</given-names></name><name name-style="western"><surname>Lage</surname><given-names>AP</given-names></name></person-group><article-title><italic toggle="yes">Brucella abortus</italic> vaccines: use in control programs and immune response</article-title><source>J Bacteriol Mycol</source><year>2017</year><volume>4</volume><fpage>1044</fpage></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morel</surname><given-names>PA</given-names></name><name name-style="western"><surname>Oriss</surname><given-names>TB</given-names></name></person-group><article-title>Crossregulation between Th1 and Th2 cells</article-title><source>Crit Rev Immunol</source><year>1998</year><volume>18</volume><fpage>275</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1615/CritRevImmunol.v18.i4.10</pub-id><pub-id pub-id-type="pmid">9704191</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>